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Research Cadmium induces Wnt signaling to upregulate 
proliferation and survival genes in sub-confluent 
kidney proximal tubule cells
Prabir K Chakraborty, Wing-Kee Lee, Malte Molitor, Natascha A Wolff and Frank Thévenod*
Abstract
Background: The class 1 carcinogen cadmium (Cd2+) disrupts the E-cadherin/β-catenin complex of epithelial 
adherens junctions (AJs) and causes renal cancer. Deregulation of E-cadherin adhesion and changes in Wnt/β-catenin 
signaling are known to contribute to carcinogenesis.
Results: We investigated Wnt signaling after Cd2+-induced E-cadherin disruption in sub-confluent cultured kidney 
proximal tubule cells (PTC). Cd2+ (25 μM, 3-9 h) caused nuclear translocation of β-catenin and triggered a Wnt response 
measured by TOPflash reporter assays. Cd2+ reduced the interaction of β-catenin with AJ components (E-cadherin, α-
catenin) and increased binding to the transcription factor TCF4 of the Wnt pathway, which was upregulated and 
translocated to the nucleus. While Wnt target genes (c-Myc, cyclin D1 and ABCB1) were up-regulated by Cd2+, 
electromobility shift assays showed increased TCF4 binding to cyclin D1 and ABCB1 promoter sequences with Cd2+. 
Overexpression of wild-type and mutant TCF4 confirmed Cd2+-induced Wnt signaling. Wnt signaling elicited by Cd2+ 
was not observed in confluent non-proliferating cells, which showed increased E-cadherin expression. Overexpression 
of E-cadherin reduced Wnt signaling, PTC proliferation and Cd2+ toxicity. Cd2+ also induced reactive oxygen species 
dependent expression of the pro-apoptotic ER stress marker and Wnt suppressor CHOP/GADD153 which, however, did 
not abolish Wnt response and cell viability.
Conclusions: Cd2+ induces Wnt signaling in PTC. Hence, Cd2+ may facilitate carcinogenesis of PTC by promoting Wnt 
pathway-mediated proliferation and survival of pre-neoplastic cells.
Background
Wnts are secreted to activate signaling processes control-
ling cell proliferation and body patterning throughout 
development. Though there are several branches of the 
Wnt-mediated signaling cascade in mammals the most 
prominent is the canonical Wnt pathway [1,2]. Its hall-
mark is the accumulation of the junctional protein β-
catenin in the cytoplasm, which then translocates to the 
nucleus to trigger the β-catenin/T-cell factor/lymphoid 
enhancer factor (TCF/LEF) transcriptional machinery, 
and upregulate target genes, such as cyclin D1, c-Myc and 
ABCB1. Under normal conditions, β-catenin is marked 
for degradation by a multi protein degradation ("destruc-
tion") complex, which maintains its levels low in the cyto-
plasm through continuous degradation by the 26S 
ubiquitin-proteasome pathway. The tumor suppressor 
protein Axin acts as the scaffold of this complex by 
directly interacting with adenomatous polyposis coli 
(APC), glycogen synthase kinase 3-β (GSK3-β), casein 
kinase 1-α (CK1-α) and β-catenin. Conversely, this pro-
cess is regulated by the Wnt signaling cascade which 
inhibits GSK3-β and thus β-catenin degradation [1,2].
Interestingly, in the cell β-catenin has two functions: (i) as 
a latent signaling molecule as part of the Wnt signaling 
pathway; and (ii) as a structural protein in adherens-junc-
tions (AJs), participating in cell-cell adhesion by bridging 
E-cadherin to α-catenin. The cadherins are Ca2+-depen-
dent cell adhesion glycoproteins that physically link 
neighboring cells together [3]). The development of AJs 
then enables the establishment of functional tight junc-
tions (TJs) which are responsible for the regulation of the 
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paracellular epithelial permeability [4]. The disruption of 
cadherin-catenin complexes causes an increase in nuclear 
β-catenin/TCF-mediated transcription of Wnt respon-
sive genes [5]. In contrast, stabilization of the cadherin-
catenin complex shows reduced β-catenin mediated Wnt 
signaling [6].
Deregulation of E-cadherin adhesion is a crucial step dur-
ing tumor cell migration, invasion and metastasis; there-
fore many epithelial cancer cells repress E-cadherin 
expression [7]. By contrast, disruption of E-cadherin cell-
cell adhesion in normal tissues induces growth arrest and 
cell death [8]. Changes of the Wnt/β-catenin signal cas-
cade can also contribute to the development of cancers. 
Furthermore, mutations in the Wnt pathway lead to 90% 
of colon cancers and also to cancers of the lungs, kidney, 
liver, etc. (reviewed in [9]). The expression of the TCF 
isoform, TCF4 is highest in organ sites with active Wnt 
signaling like the central nervous system and intestinal 
epithelium, but also kidney. Hence loss of cell-cell adhe-
sion and uncontrolled Wnt signaling promote cancer 
induction and progression.
Cadmium and cadmium compounds are group 1 human 
carcinogens [10]. The evidence for carcinogenicity in 
humans is also supported by recent epidemiologic evi-
dence indicating that cadmium induces cancer in many 
organs in humans, including the kidneys [11,12]. The 
present consensus is that a direct mutagenic effect of cad-
mium is weak [13], but is presumably sufficient to induce 
tumors if combined with other pro-carcinogenic effects 
of cadmium, such as formation of reactive oxygen species 
(ROS) and/or interference with anti-oxidative enzymes, 
inhibition of DNA repair enzymes, deregulation of cell 
proliferation, interference with the balance between pro 
and anti-apoptotic mechanisms, and disruption of cell 
adhesion [14].
One early event associated with cadmium ion (Cd2+) 
nephrotoxicity is the alteration of the properties of AJs 
and TJs, most likely due to Ca2+ displacement, which 
causes disruption of the homophilic E-cadherin interac-
tion [15]. This causes a loss of integrity in the cell-cell 
adhesion belt and disassembly of TJs with a concomitant 
decrease in the trans-epithelial resistance and increased 
paracellular permeability (reviewed in [16]). In a recent 
study, we confirmed that micromolar Cd2+ concentra-
tions decrease trans-epithelial resistance of cultured 
WKPT-0293 Cl.2 rat kidney proximal tubule cells (PTC) 
within 1 hour of exposure which correlated with a 
decrease of membrane-associated E-cadherin and β-
catenin and an increase of c-Myc and Abcb1 mRNA after 
3 hours [17]. Hence, the present study sought to investi-
gate the impact of disruption of AJs by Cd2+ on β-catenin/
Wnt signaling in cultured kidney PTC. The data demon-
strate that Cd2+ induces Wnt signaling in PTC to upregu-
late proliferation and survival genes.
Methods
Materials and antibodies
Cycloheximide and actinomycin D were purchased from 
Roth (Karlsruhe, Germany), lactacystin, rabbit serum 
(cat. #S2632) and protease inhibitor cocktail were 
obtained from Sigma-Aldrich (Deisenhofen, Germany). 
Recombinant protein G sepharose 4B was from Invitro-
gen (Karlsruhe, Germany). Antibodies (all mouse mono-
clonal) used were: anti-β-catenin (cat. # 610153; 1:1000) 
and anti-E-cadherin (cat. #610181; 1:2500) from BD Bio-
sciences (Heidelberg, Germany), anti-α-catenin (cat. # 
ab19446; 1:1000) from Abcam (Cambridge, UK), anti-
CHOP (clone9C8) (cat. # MA1-250; 1:1000) from 
Dianova GmbH (Hamburg, Germany), anti-TCF4 
(clone6H5-3) (cat. # 05-511; 1:1000) from Millipore 
GmbH (Schwalbach, Germany), anti-GAPDH (cat. # 
G8795; 1:20,000), anti-β-actin (cat. # A5316; 1:10,000) 
and anti-γ-tubulin (cat. # T6557; 1:10,000) from Sigma-
Aldrich. The secondary sheep anti-mouse horseradish 
peroxidase (HRP)-linked IgG (NA931; 1:5000) was pur-
chased from Amersham Biosciences (Freiburg, Ger-
many). All other chemicals were of the highest purity 
grade available.
Cell culture
Cells from the S1-segment of rat PT (WKPT-0293 Cl.2) 
were immortalized by retroviral transfection with SV40 
large T-antigen [18] and cultured as previously described 
[19] at 37°C in 5% CO2. Apart from some ECIS experi-
ments (see below), all Cd2+ experiments were performed 
in serum-free medium (SFM). Unless otherwise indi-
cated, 25 μM Cd2+ was used. For immunoblot experi-
ments comparing subconfluent and confluent cells ~50% 
confluence was obtained by seeding 5 × 105 cells per well 
and 100% confluence by seeding 1 × 106 cells per well in 
6-well plates. After 48 hours WKPT-0293 Cl.2 cells were 
incubated in the absence or presence of Cd2+ in SFM 
before harvesting.
Preparation of cytosolic and nuclear protein extracts
The protocol was adapted from the method described by 
Andrews and Faller [20]. Cells were harvested into 400 μl 
of ice cold buffer A (10 mM HEPES-KOH, pH 7.9, 1.5 
mM MgCl2, 10 mM KCl, 0.5 mM DTT, 0.05% Nonidet P-
40, 0.2 mM Pefabloc SC and a protease inhibitor cock-
tail), and allowed to lyse on ice for 10 min. After a pre-run 
at 4°C at 500 × g for 1 min to remove unlysed cells and 
debris, further centrifugation was performed at 16,000 × 
g for 1 min. The supernatant containing cytosolic pro-
teins was collected. Exactly 100 μl of buffer B (20 mM 
HEPES-KOH, pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 
mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.05% Nonidet 
P-40, 0.2 mM Pefabloc SC and protease inhibitor cock-
tail), was added to the pellet and incubated on ice for 20 Chakraborty et al. Molecular Cancer 2010, 9:102
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min. The suspension was centrifuged at 16,000 × g for 2 
min and the supernatant containing the nuclear proteins 
was collected.
Immunoblotting
Protein concentration of samples was determined by the 
Bradford method [21], using bovine serum albumin as a 
standard. SDS-PAGE and transfer were performed 
exactly as described elsewhere [17]. Signals were quanti-
fied using ImageJ or TINA 2.09 software. For compari-
sons between control and experimental conditions 
specific signals were first normalized to loading markers 
(β-actin, γ-tubulin or GAPDH).
Immunoprecipitation
All steps were performed at 4°C. Cells (150-300 μg) were 
lysed in 250 μl of RIPA buffer (50 mM Tris-HCl, pH 8.0, 
150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxy-
cholate, 0.1% SDS) and 10 μl protease inhibitor cocktail). 
The solution was centrifuged at 15,800 × g to remove par-
ticulate matter. Lysate containing 150 μg of protein was 
pre-cleared with rabbit serum and recombinant protein 
G sepharose 4B, mixed with 4 μg/ml of antibody to β-
catenin or TCF4 for 16 hours at 4°C and then collected 
using protein G sepharose 4B by incubation for 30 min. 
Immunoprecipitates were washed three times with RIPA 
buffer. After centrifugation, the pellets were resuspended 
in sample buffer and heated for 5 min at 95°C for SDS-
PAGE, followed by immunoblot analysis.
Laser scanning confocal and immunofluorescence 
microscopy
Cells (5 × 104) were grown in 24-well plates on glass 
cover-slips. After treatment coverslips were washed with 
PBS, fixed with 4% paraformaldehyde in PBS, permeabi-
lized with 0.2% TritonX-100 for 5 min, and blocked with 
1% BSA and 100 μg/ml RNAse A for 2 h. Thereafter, the 
cells were incubated with primary antibodies against β-
catenin (1:1000), TCF4 (1:250) or E-cadherin (1:1000) fol-
lowed by staining with anti-mouse Alexa-Fluor 488 con-
jugated secondary antibody (1:400) (Invitrogen GmbH; 
Karlsruhe, Germany) for 1 h and subsequent propidium 
iodide (PI) staining (10 μg/ml) for 5 min. Then the cells 
were washed and samples were visualized with a LEICA 
TCS SP5 confocal laser microscope (Wetzlar, Germany) 
by exciting at 488 nm (emission 520 nm) to detect β-
catenin and TCF4, and at 543 nm (emission 617 nm) for 
PI. E-cadherin overexpressing and mock-transfected cells 
were viewed with a Zeiss Axiovert 200 M microscope 
(Carl Zeiss, Jena, Germany) using filters for FITC with 
excitation/emission wavelengths of 480/535 nm, respec-
tively. Images were acquired at fixed exposure times (600 
ms), processed, and analyzed semiquantitatively with 
MetaMorph software (Universal Imaging Corporation, 
Downingtown, PA).
Electrophorectic mobility shift assay (EMSA)
Nuclear fractions were used for EMSA of TCF4 binding 
to cyclin D1 and ABCB1 promoters. Based on the consen-
sus TCF/LEF-binding motifs, CTTTGA/TA/T [22] the 
wild-type TCF/LEF binding sequence of the human 
cyclin D1 promoter 5'-CTCTGCCGGGCTTT-
GATCTTTGCTTAACA-3' [23] and the binding 
sequence of human ABCB1 5'-GGCTTTGAAGTATGA-
3' [24] were selected. They were end-labeled with [γ-32P] 
dATP by incubating oligodeoxyribonucleotide strands 
with 5× reaction buffer and 10 U T4 polynucleotide 
kinase (Fermentas, St. Leon-Rot, Germany) for 1 h at 
37°C. Then labeled oligonucleotides were allowed to 
anneal at room temperature for 10 min and 20 μg protein 
from each sample was used in 25 μl binding reactions, 
which consisted of 1 μg poly dI-dC, in 5× binding buffer 
(50 mM Tris HCl;pH 8.0, 750 mM KCl, 2.5 mM EDTA, 
0.5% Triton-X 100, 62.5% glycerol (v/v) and 1 mM DTT). 
To determine specificity of DNA binding, samples were 
incubated with or without 20 ng of unlabeled competitor 
DNA for 10 min at room temperature. Then 0.1 ng of 
labeled probe was added and samples were further incu-
bated for 20 min at room temperature. Samples were sep-
arated on a 5% non-denaturing polyacrylamide gel in 
0.5% TBE and visualized by autoradiography.
RT-PCR
Total RNA was extracted using the RNeasy Mini Kit 
(Qiagen, Hilden, Germany) and first strand cDNA was 
synthesized with the Omniscript RT kit (Qiagen), using 1 
μg of RNA per 20 μl reaction and oligo(dT) primer. cDNA 
was then utilized in PCR reactions for c-Myc and GAPDH 
as previously described [17]. Remaining primers are sum-
marized in the Additional file 1.
Following activation at 95°C for 15 min, the following 
PCR conditions for each primer pair were performed: For 
Lef-1, TCF-3, TCF-4, E-cadherin and β-catenin 28 cycles 
at 94°C for 20 s, 62°C for 30 s, 72°C for 45 s; for cyclin D1 
34 cycles at 94°C for 30 s, 56°C for 60 s, 72°C for 90 s; for 
Abcb1a 32 cycles at 95°C for 80 s, 56°C for 60 s and 72°C 
90 s; for CHOP 28 cycles at 94°C for 30 s, 62°C for 30 s 
and 72°C for 45 s.
Plasmids and transient transfections
Myc-epitope-tagged full length human TCF4 and a dele-
tion mutant lacking the NH2-terminal 30 amino acids 
(ΔN-hTCF4), which are essential for its interaction with 
β-catenin, were inserted in the expression vector 
pcDNA3 [25] and were a gift of Dr. Bert Vogelstein (Balti-
more, Maryland, USA). Full-length E-cadherin inserted 
into the plasmid pL31NU [26] was a gift of Dr. Rolf Kem-Chakraborty et al. Molecular Cancer 2010, 9:102
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ler (Freiburg Germany), the full length mouse CHOP 
construct in pcDNA1 was a gift of Prof. David Ron (New 
York, NY, USA) and the ΔN-β-catenin construct in 
pCGN lacking the NH2-terminal stretch of 132 amino 
acids required for its degradation [27] was a gift of Prof. 
Avri Ben-Ze'ev (Rehovot, Israel).
Unless otherwise indicated, WKPT-0293 Cl.2 cells (5 × 
105 cells per well in 6-well plates) were transiently trans-
fected 24 h post-seeding with the various constructs 
using Lipofectamine 2000 reagent (Invitrogen) following 
manufacturer's instructions. Plasmids and Lipofectamine 
reagent were used at a constant ratio of 1:2.5 and incu-
bated for up to 36 h.
Luciferase assay
Wnt signaling was assessed using the well-described 
TOPflash assay [25]. Briefly, 5 × 104 cells per well grown 
for 24 h in 24-well plates were transiently transfected 
with TOPflash or FOPflash (Millipore) using poly(ethyle-
neimine) (PEI; Sigma) from a stock solution of 1 mg/ml at 
a ratio of 1:0.75 (volume DNA:volume PEI). For experi-
ments with ΔN-β-catenin, cells were first transfected 
with ΔN-β-catenin construct and then with TOPflash or 
FOPflash 6 h later. Luciferase activity was determined 
using Tropix Luminescence assay kit (Applied Biosystems 
Applera Deutschland GmbH, Darmstadt, Germany) after 
24 h and the measurements were performed in a Mithras 
LB 940 multimode microplate reader (Berthold Technol-
ogies GmbH, Bad Wildbad, Germany). The readings were 
normalized against protein concentration determined by 
the Bradford method [21] for each sample. For experi-
ments with ~50% confluent or 100% confluent cells 5 × 
104 and 9 × 104 cells per well, respectively, were grown in 
24-well plates. The degree of cell confluence refers to the 
time of transfection with TOPflash or FOPflash.
MTT toxicity assay
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT) method was modified as previously 
described [17] and measured on a Helios Epsilon spectro-
photometer (Thermo Scientific, Langenselbold, Ger-
many). The values were normalized to the control, which 
was equivalent to 100% cell viability, to determine cell 
death rates. To account for the loss of cells during the 
transfection procedure, different cell numbers (1.5 × 104 
for empty vector and CHOP, 2.5 × 104 for E-cadherin in 
48 well plates) were plated to obtain a similar cell density 
prior to treatment with Cd2+.
Electric cell-substrate impedance sensing (ECIS)
Eighteen to 24 hours after transfection, WKPT-0293 Cl.2 
cells were trypsinized, centrifuged at 400 × g for 5 min, 
and plated in ECIS 8W10E cell culture arrays at 3.5 - 5.5 × 
105 cells per well. For experiments evaluating the effect of 
Cd2+ on the attachment and proliferation of CHOP-trans-
fected cells serum-containing medium (SCM) included 
50 μM CdCl2. The changes in resistance (R) and capaci-
tance (C) of the recording electrodes were determined 
using an ECIS™1600R instrument (Applied BioPhysics, 
Troy, NY), as previously described [17]. C40 kHz and R400 Hz 
values reflect electrical properties of epithelial monolay-
ers due to cell attachment/spreading/proliferation and 
barrier formation, respectively. Whereas C40 kHz mirrors 
attachment and spreading of cells R400 Hz values are indic-
ative of the epithelial barrier integrity, especially estab-
lishment of tight intercellular contacts. For experiments 
evaluating cell attachment and proliferation, the cells 
were incubated in SCM, with twice daily medium 
renewal. Once the cells had established a functional 
monolayer with stable R and C readings, they were 
washed once with SFM and the medium was replaced 
with SFM ± 20 μM Cd2+.
Determination of cellular levels of reactive oxygen species 
(ROS)
The nonfluorescent, dye 5-(and-6)-carboxy-2',7'-dichlo-
rodihydrofluorescein diacetate (carboxy-H2DCFDA) is 
oxidized to fluorescent carboxydichlorofluorescein by 
H2O2, peroxyl radicals and peroxynitrite anion (Invitro-
gen GmbH; Karlsruhe, Germany). WKPT-0293 Cl.2 cells 
(2 × 105; 6-well plates) were loaded with 20 μM carboxy-
H2DCFDA, in the presence of the ABCB1 inhibitor 
PSC833 (1 μM) to improve dye loading, for 30 min at 
37°C. After washing, cells were gently trypsinized, pel-
leted by centrifugation at 400 × g for 3 min, brought into 
suspension, and added to each well of a 96 well plate ± 
Cd2+. Data were collected every 60 sec at λex/λem of 500/
535 nm on a Berthold Mithras LB940 fluorescence 
microplate reader. When used, cells were pre-incubated 
with 100 μM α-tocopherol for 1 h prior to dye loading 
and remained in the presence of α-tocopherol for the 
duration of the measurements.
Statistics
Unless otherwise indicated, the experiments were always 
repeated at least three times with independent cultures. 
Means ± SEM are shown, unless otherwise indicated. Sta-
tistical analysis using unpaired Student's t-test was car-
ried out with Sigma Plot 8.0 (Inc., Chicago, IL). For more 
than two groups, one-way ANOVA was used assuming 
equality of variance with Levene's test and Tukey post hoc 
test for pair-wise comparison with SPSS 12.0. Results 
with P < 0.05 were considered to be statistically signifi-
cant.Chakraborty et al. Molecular Cancer 2010, 9:102
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Results
Cd2+ disrupts the E-cadherin-catenin adherens junction 
complex and causes translocation of β-catenin to cytosol 
and nuclei of kidney PTC
One early event associated with Cd2+ nephrotoxicity is 
disruption of the homophilic E-cadherin interaction 
[15,16]. In the present study, exposure of sub-confluent 
WKPT-0293 Cl.2 cells to Cd2+ (25 μM in SFM) for 3-9 h 
led to cytoplasmic and nuclear accumulation of β-catenin 
(Fig. 1A), indicating disruption of the AJ complex. Statis-
tical analysis of 3 different experiments displays signifi-
cant β-catenin increase in cytosol already after 3 h and in 
nuclei after 6 h. This was corroborated by confocal 
immunofluorescence microscopy of Cd2+ treated PTC 
which exhibited a more diffuse β-catenin distribution in 
the cytoplasm and nucleus compared to the controls 
where β- catenin was predominately found at the cell bor-
ders (Fig. 1B).
A possible explanation for the higher levels of β-catenin is 
increased synthesis induced by Cd2+. However, mRNA 
levels of β-catenin were unchanged by Cd2+ (Additional 
file 2a) and the translation inhibitor cycloheximide had 
no effect on Cd2+-induced β-catenin redistribution 
(Additional file 2b). To find out whether the increase in β-
Figure 1 Cd2+ disrupts the adherens junction complex and redistributes β-catenin from the periphery to cytosol and nuclei of kidney PTC. 
(A) Time dependent increase of β-catenin protein distribution in cytoplasmic and nuclear fractions of WKPT-0293 Cl.2 cells without (ctl) or with Cd2+. 
Cytosolic and nuclear fractions were immunoblotted with β-catenin antiserum. For loading controls, the same membranes were reprobed with anti-
bodies to β-actin and γ-tubulin for cytoplasmic and nuclear fractions, respectively. β-catenin signals were normalized to loading markers and com-
pared to controls, which were set to 100%. Means ± SEM of 3 experiments are shown. One-way ANOVA was used assuming equality of variance with 
Levene's test and Tukey post hoc test for pair-wise comparison between control and Cd2+ exposed cells. (B) Immunofluorescence staining patterns 
of β-catenin in WKPT-0293 Cl.2 cells ± Cd2+. Nuclei were stained with propidium iodide (PI). Note the peripheral β-catenin labeling in control cells 
whereas in Cd2+ exposed cells β-catenin is found diffusely distributed in cytosol and nuclei. Bars = 20 μm. (C) Distribution of α-catenin in cytoplasmic 
and nuclear fractions increases with Cd2+ exposure time, as shown by immunoblotting. (D) Cd2+ reduces association of β-catenin with E-cadherin and 
α-catenin as a function of time. Cell lysates were immunoprecipitated (IP) with β-catenin antiserum and immunoblotted (IB) with E-cadherin or α-
catenin antisera.
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catenin might be due to inhibition of the proteasomal 
degradation complex by Cd2+, we utilized lactacystin, a 
potent proteasomal inhibitor. After 6 h the increase of the 
cytosolic and nuclear pool of β-catenin observed with 
Cd2+ was not mimicked by lactacystin (Additional file 2c), 
indicating that Cd2+ does not inhibit the proteasome. 
Thus the elevation of β-catenin must be a consequence of 
redistribution of β-catenin from the membrane pool to 
cytosol and nuclei.
Alpha-catenin is another member of the AJ complex 
assembly, which mediates interaction between AJs and 
actin filaments, therefore disruption of the complex 
should also lead to the release of α-catenin. Similarly to β-
catenin, α-catenin content in the cytoplasm and nuclei 
steadily increased under Cd2+ treatment of sub-confluent 
WKPT-0293 Cl.2 cells at 3-9 h (Fig. 1C). β-catenin/TCF/
LEF1 mediated transcription has been reported to be 
inactivated through β-catenin binding to E-cadherin [28] 
or α-catenin [29]. However, binding of β-catenin to E-
cadherin as well as α-catenin is reduced by Cd2+ exposure 
(Fig. 1D), supporting the disruptive action of Cd2+ on the 
AJ and negating the probability of transcriptional inacti-
vation of β-catenin by α-catenin.
Cd2+ exposure induces translocation of TCF4 to the nucleus 
and activation of the canonical Wnt/β-catenin pathway in 
PTC
The pivotal transcription factor for the canonical Wnt 
pathway, the TCF4 protein, is responsible for transactiva-
tion of cell proliferation and survival genes. Strikingly, we 
observed increased localization of TCF4 in nuclei upon 
Cd2+ exposure from an early time point of 3 h and 
remained elevated up to 9 h (Fig. 2A). This could also be 
visualized in confocal laser scanning micrographs (data 
not shown). A prerequisite for activation of the Wnt 
pathway-mediated expression of target genes is binding 
of β-catenin to TCF4 in the nucleus. To evidence this, 
immunoprecipitation was performed with β-catenin and 
bound TCF4 was determined by immunoblotting. Cd2+-
treated samples exhibited more β-catenin-TCF4 binding 
as early as 3-6 h (Fig. 2B). To confirm β-catenin/TCF4 
interaction, we repeated the experiment at 3-9 h Cd2+ 
incubation by pulling down TCF4 and immunoblotting 
for β-catenin (Additional file 3a) thus establishing that 
there is significantly more β-catenin bound to TCF4 
under Cd2+ treatment conditions.
To assess the activation of the Wnt transcriptional 
machinery upon Cd2+ exposure, we performed luciferase 
activity measurements using the TOPflash reporter con-
struct, which contains optimal TCF binding sites, in sub-
confluent WKPT-0293 Cl.2 cells. Cd2+ maximally 
increased TOPflash activity starting at 3-6 h but termi-
nated at 12 h. After 6 h, the TCF reporter activity was 
1.81 ± 0.21-fold (means ± SEM of 8 experiments; P = 
0.009) (Fig. 2C). FOPflash activity, a negative control, was 
not affected by Cd2+ (data not shown). For comparison, 
transfection of PTC with a ΔN β-catenin, which is resis-
tant to proteasomal degradation [30] resulted in a 5.7 ± 
1.5 fold (means ± SEM of 4 experiments; P = 0.02) 
increase of luciferase activity, compared to the control 
vector (Fig. 3B). The expression of Wnt signaling target 
genes involved in cell proliferation and survival, c-Myc, 
cyclin D1 and Abcb1a, was also increased by Cd2+ expo-
sure for up to 12 h (Fig. 2D). Experiments using EMSAs 
showed binding of TCF4 to the promoter sequence of 
both ABCB1 (Fig. 2E) and cyclin D1 (Additional file 3b) 
that was enhanced by Cd2+ for up to 9 h, but peaked at 3 
h. In order to assure that β-catenin was responsible for 
the transcription of target genes via the β-catenin/TCF4 
transcription factor complex, we over-expressed wild-
type hTCF4 and mutant ΔN-hTCF4. This mutant form of 
TCF4 lacks the NH2-terminal region required for interac-
tion with β-catenin [25]. Cd2+ (25 μM for 3-6 h) increased 
the expression of c-Myc in wild-type TCF4 over-express-
ing cells more profoundly than in vector-transfected or 
ΔN-hTCF4 mutant transfected cells (Fig. 2F). This con-
firms the role of β-catenin in mediating the up-regulation 
of Wnt target genes under Cd2+ exposure of kidney PTC.
Cd2+-induced Wnt signaling is triggered in non-confluent 
and proliferating but not in confluent and quiescent PTC
Interestingly, we found that the Wnt response activated 
by Cd2+ is dependent on the confluence and proliferation 
status of the cells. With 100% confluent cells, we did not 
detect β- and α-catenin translocation to the cytosol and 
nuclei of Cd2+-exposed PTC, in contrast to ~50% conflu-
ent cells (Fig. 3A). This was associated with markedly 
reduced TOPflash activity. As shown in Fig. 3B, there was 
increased nuclear β-catenin bound to TCF4 in ~50% con-
fluent cells but not in 100% confluent cells exposed to 
Cd2+. Moreover, ~50% confluent cells exhibited an ~2-
fold increase in TOPflash transcriptional activity upon 
exposure to 25 μM Cd2+ for 6 h (P = 0.007), whereas 100% 
confluent cells were not responsive (Fig. 3C). We also 
observed higher E-cadherin expression in 100% confluent 
than in ~50% confluent cells (Fig. 3D). Since β- and α-
catenin are associated with E-cadherin at the AJ, it could 
account for the observed dependency of Cd2+ to induce 
Wnt signaling on confluence.
Role of E-cadherin expression levels in Cd2+-induced 
nuclear translocation of β-catenin and cell fate
To test the hypothesis that high levels of E-cadherin could 
prevent nuclear β-catenin translocation and Wnt signal-
ing induced by Cd2+, we overexpressed full-length E-cad-
herin in WKPT-0293 Cl.2 cells. E-cadherin expression 
was increased by ~70% and was found to be uniformly Chakraborty et al. Molecular Cancer 2010, 9:102
http://www.molecular-cancer.com/content/9/1/102
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distributed at the cell borders (Additional file 4a). When 
cells were subjected to 25 μM Cd2+ for 6 h, the increase in 
cytoplasmic and nuclear β-catenin induced by Cd2+ was 
abolished in E-cadherin overexpressing cells (Fig. 4A).
Because Cd2+-induced β-catenin translocation to the 
nucleus triggers β-catenin/TCF4-mediated Wnt signaling 
and increases expression of cell proliferation genes (see 
Fig. 2), we investigated the impact of E-cadherin on cell 
proliferation by ECIS. The ECIS technique measures the 
electrical properties of epithelial monolayers due to cell 
attachment/spreading/proliferation and barrier forma-
tion. C40 kHz reflects attachment, spreading and prolifera-
tion of cells whereas R400 Hz replicates epithelial barrier 
integrity and establishment of tight intercellular contacts 
(see Methods). C40 kHz for control cells decreased from 
values of the cell-free electrode to its baseline values (8-
10 nF) after ~20 h (Fig. 4B), reflecting the establishment 
of an intact monolayer with coverage of the whole elec-
trode surface. In contrast, E-cadherin over-expression in 
WKPT-0293 Cl.2 cells significantly retarded cell prolifer-
ation. Interestingly, however, once a stable monolayer was 
established, E-cadherin over-expressing cells were less 
sensitive to Cd2+ (Fig. 4C). The decrease of R400 Hz, indica-
tive of a disruption of the epithelial barrier, became 
Figure 2 Cd2+ triggers nuclear translocation of TCF4 and activates TCF4/β-catenin mediated transcription of cell proliferation and survival 
genes in kidney PTC. (A) Distribution of TCF4 protein in cytoplasmic and nuclear fractions of WKPT-0293 Cl.2 cells ± Cd2+ was determined by immu-
noblotting. (B) Increased association of immunoprecipitated β-catenin with TCF4 by Cd2+ in WKPT-0293 Cl.2 cells. (C) Cd2+ induces TCF transcriptional 
activity. Luciferase activity of TOPflash or FOPflash transfected cells treated with 25 μM Cd2+ for 3-12 h. Data were corrected for protein and normalized 
to controls at each time point. Means ± SEM (n = 3-8) are shown. Student's unpaired t-test compares Cd2+ treated cells to respective controls. (D) Effect 
of Cd2+ exposure on mRNA of Wnt pathway target genes. GAPDH was used as housekeeping gene. (E) EMSA of TCF4 binding to the ABCB1 promoter 
region. Extracts from controls (ctl), Cd2+ (25 μM) treated cells, cells exposed to 3 h Cd2+ followed by incubation with a 200-fold excess of competing 
unlabeled oligonucleotides (comp.), and lysate-free sample (blank) were loaded. Binding of oligonucleotides to TCF4 was enhanced upon Cd2+ expo-
sure. (F) Effect of TCF4 overexpression on Cd2+ induced c-Myc mRNA expression. WKPT-0293 Cl.2 cells transiently transfected with full length human 
TCF4 (TCF4), human TCF4 lacking the interaction domain for β-catenin (ΔN-TCF4), or empty vector were treated with ± 25 μM Cd2+. TCF4 overexpres-
sion enhanced basal and Cd2+-induced c-Myc expression, whereas ΔN-TCF4 had no effect.
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apparent within hours after addition of 20 μM Cd2+ in 
serum-free medium in vector-transfected cells, but pro-
ceeded far more slowly in E-cadherin over-expressing 
cells. Corresponding ΔC40 kHz increased by 1.76 ± 0.20 
nF/h in vector-transfected cells as opposed to 0.91 ± 0.35 
nF/h in E-cadherin-transfected PTC (means ± SEM of 3 
experiments) reflecting increased detachment of cells 
from the electrode. This suggested that E-cadherin over-
expression not only protects the epithelial monolayer 
from Cd2+-induced disruption of cellular junctions but 
also from detachment and death.
This was further tested by investigating the impact of E-
cadherin overexpression on cell viability of WKPT-0293 
Cl.2 cells exposed to Cd2+. Transfected cells were treated 
with 25 μM Cd2+, assessed using the MTT assay. Follow-
ing treatment with Cd2+, cell viability decreased by ~30% 
in vector-transfected cells. Conversely, Cd2+ could 
decrease cell viability by only ~9% in E-cadherin over-
expressing cells (P < 0.01) (Fig. 4D). Taken together, these 
data indicate that E-cadherin overexpression decreases 
Wnt signaling-mediated cell proliferation and in conflu-
ent PTC monolayers is protective against Cd2+-induced 
disruption of the cellular junctions, detachment and cell 
death.
Figure 3 Cd2+-induced nuclear translocation of β-catenin and Wnt signaling are abolished in confluent kidney PTC, which show increased 
E-cadherin expression. (A) Immunoblots with β-catenin or α-catenin antisera in ~50% and 100% confluent WKPT-0293 Cl.2 cells (25 μM Cd2+, 6 h). 
For statistical analysis of immunoblots β-catenin signals were normalized to the loading markers and compared to controls, which were set to 100%. 
Means ± SEM (n = 3) are shown. Student's unpaired t-test compares Cd2+ treated cells to respective controls. (B) Cd2+-induced TCF transcriptional ac-
tivity depends on the confluence of kidney PTC. WKPT-0293 Cl.2 cells transfected with TOPflash, FOPflash or ΔN-β-catenin were treated with 25 μM 
Cd2+ for 6 h. Data presented are means ± SEM of 4-5 experiments. Student's unpaired t-test compares Cd2+ treated or ΔN-β-catenin-transfected cells 
to respective controls. (C) To determine association of TCF4 with β-catenin in ~50% and 100% confluent cells, nuclear fractions were immunoprecip-
itated with an antibody against β-catenin and immunoblotted for TCF4. (D) Expression of E-cadherin in whole cell lysates of ~50% and 100% confluent 
cells by immunoblotting.
A
cytosol
nuclei
homogenate
-  +         -  +    Cd2+
~50% confl. 100% confl.
-actin
-catenin
-tubulin
-catenin
-catenin
-catenin
-catenin
-catenin
C
d
2
+
-
i
n
d
u
c
e
d
 

-
c
a
t
e
n
i
n
 
t
r
a
n
s
l
o
c
a
t
i
o
n
(
%
 
o
f
 
c
o
n
t
r
o
l
)
0
200
400
600
800
1000
1200
50% confluent 
100% confluent
cytosol nuclei
*
*
*P<0.01
B
TCF4
IP: -catenin
IB:
-  +         -  +     Cd2+
~50% confl. 100% confl.
-tubulin
D
~50% confl.
100% confl.
E-cadherin
Luciferase activity (fold induction)
02468
Control
Control
Control
N -cat.
Cd
2+
*
*
*P<0.025
Cd
2+
~50%
confl.
100%
confl.
CChakraborty et al. Molecular Cancer 2010, 9:102
http://www.molecular-cancer.com/content/9/1/102
Page 9 of 16
Cd2+-induced ROS formation increases CHOP expression 
but does not antagonize Wnt signaling
ROS can be generated by Cd2+ [31] and are known to dis-
rupt TJs and AJs resulting in decreased transepithelial 
electrical resistance and redistribution of β-catenin [32]. 
Thus, we investigated whether the β-catenin accumula-
tion in cytosol and nuclei is ROS-dependent. As shown in 
Fig. 5A, Cd2+ (25 μM) caused an increase in ROS within 
minutes after Cd2+ exposure which was determined by 
oxidation of the fluorescent probe carboxy-H2-DCFDA. 
ROS formation steadily increased over time reaching 30 ± 
9% above controls at 2 h exposure (P < 0.01; n = 3), which 
was prevented by the antioxidant α-tocopherol (100 μM) 
(Fig. 5A). But Cd2+ exposure showed similar effects on β-
catenin distribution into the cytosol of PTC whether in 
the presence or absence of α-tocopherol (Fig. 5B), indi-
cating that β-catenin release from the membrane and E-
cadherin-bound pool to the intracellular space is ROS-
independent.
CHOP, also known as GADD153, is a pro-apoptotic pro-
tein that is involved in the endoplasmic reticulum (ER) 
stress pathway. Increased expression of CHOP has been 
previously reported in the presence of Cd2+ in kidney 
PTC as a function of ROS formation [33]. Moreover, 
Figure 4 E-cadherin overexpression in kidney PTC abolishes β-catenin redistribution, decreases proliferation and protects against Cd2+-
induced epithelial barrier disruption and cytotoxicity. (A)β-catenin immunoblots of WKPT-0293 Cl.2 cells transiently transfected with full length 
E-cadherin expression plasmid (E-cadherin) or empty vector (vector) and incubated for 6 h ± 25 μM Cd2+. β-catenin signals were normalized to loading 
markers and the ratio of β-catenin in Cd2+ and respective control samples was determined. Means ± SEM (n = 7) are shown. Student's unpaired t-test 
compares Cd2+ treated cells to respective controls. (B) Vector or E-cadherin PTC were reseeded in SCM in ECIS 8WE10 arrays. C40 kHz reflects cell attach-
ment, spreading and proliferation (see Methods). Initial values of the cell-free electrode were set to 100% (vector, 63.5 ± 1.9 nF; E-cadherin, 65.2 ± 3.3 
nF; means ± SEM of 3 experiments). Data show means ± SEM of 3 experiments. (C) At confluence PTC were exposed to SFM ± 20 μM Cd2+. Values of 
the confluent cell-covered electrode were set to 100% (vector, 3670 ± 83 ohm; E-cadherin, 2994 ± 300 ohm; means ± SEM of 3 different experiments). 
A drop in R400 Hz indicates disruption of epithelial barrier and cell detachment. (D) Vector or E-cadherin cells were exposed to 25 μM Cd2+ for 6 h and 
cell viability was determined by MTT assay. Graph depicts means ± SEM of 9-10 experiments. Student's unpaired t-test compares Cd2+ treated cells to 
respective controls as well as Cd2+-exposed vector to Cd2+-exposed E-cadherin cells.
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CHOP has been previously shown to negatively regulate 
the Wnt signaling pathway through binding to TCF4 [34]. 
We also found that Cd2+ treatment (25 μM) of WKPT-
0293 Cl.2 cells increased the expression of CHOP in a 
time dependent manner (up to 18 h) (Fig. 5C), which was 
abrogated in the presence of α-tocopherol (Fig. 5D). 
CHOP was pulled down with TCF4 in immunoprecipita-
tion experiments confirming CHOP-TCF4 interaction. 
This was further enhanced by Cd2+ exposure (25 μM for 6 
h) (Fig. 5E). Next, we investigated the expression of the 
Wnt target gene c-Myc in cells over-expressing CHOP. 
When treated with Cd2+, CHOP-overexpressing cells still 
showed an increment of c-Myc expression, indicating that 
CHOP does not prevent Cd2+-induced Wnt signaling 
(Fig. 5F). Cell viability studies with Cd2+ for 6 h (Addi-
tional file 4b) or 12 h (data not shown) showed no effect 
of CHOP overexpression on Cd2+-induced cell death in 
PTC. Similarly, measurements of cell proliferation dem-
onstrated that CHOP overexpression had no effect on 
proliferation in Cd2+-exposed cells (data not shown). 
Both findings are in accordance with the c-Myc expres-
sion data (Fig. 5F). From these data, we concluded that 
CHOP plays no significant role in preventing cell prolifer-
ation and survival of PT cells following Cd2+ exposure 
though CHOP does bind to TCF4 (see Fig. 5E).
Cd2+ increases TCF4 expression which may override CHOP 
inhibition of Wnt signaling
A possible reason for the discrepancy between our data 
and the literature may be the striking observation of 
Figure 5 Cd2+-induced reactive oxygen species (ROS) formation in kidney PTC induces up-regulation of CHOP, but has no effect on Wnt 
signaling. (A) When used, the ROS scavenger α-tocopherol was pre-incubated for 1 h. Cells were loaded with 20 μM carboxy-H2DCFDA. Cell suspen-
sions were incubated with Cd2+ ± α-tocopherol and fluorescent signals were measured immediately at 500/535 nm. Graph shows means ± SEM of 4-
7 experiments. (B) β-catenin immunoblot of WKPT-0293 Cl.2 cells ± α-tocopherol (TOCO) (100 μM) ± 25 μM Cd2+ for 6 h. (C) Expression of CHOP mRNA 
in WKPT-0293 Cl.2 cells without (ctl) or with 25 μM Cd2+ by RT-PCR. (D) Prevention of Cd2+-mediated increase in CHOP mRNA expression by α-tocoph-
erol. (E) Association of CHOP with TCF4 is increased in WKPT-0293 Cl.2 cells incubated with 25 μM Cd2+ for 6 h when compared to controls (ctl). (F) 
Effect of CHOP overexpression on Cd2+-induced expression of c-Myc by RT-PCR. PTC transiently transfected with full length human CHOP (CHOP) or 
empty vector (vector) were exposed to 25 μM Cd2+.
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increased total TCF4 elicited by Cd2+ exposure from an 
early time point of 3 h up to 9 h Cd2+ at the protein (Fig. 
6A) and mRNA (Fig. 6B) levels. Moreover, TCF4 up-reg-
ulation by Cd2+ in sub-confluent cells was strongly 
reduced in confluent monolayers (Fig. 6C). To strengthen 
our observation that TCF4 up-regulation by Cd2+ is at the 
transcriptional level, we used the transcriptional inhibitor 
actinomycin D. In the presence of actinomycin D (10 μg/
ml, pre-incubated for 1 h), Cd2+ treatment failed to up-
regulate TCF4 protein, when compared to cells treated 
with Cd2+ alone (Fig. 6D). Hence increased TCF4 expres-
sion may override CHOP inhibition.
In contrast to the effect of Cd2+ on TCF4, additional tran-
scriptional components of Wnt/β-catenin signaling were 
not up-regulated by Cd2+ exposure in sub-confluent PTC. 
TCF3 mRNA levels were similar in control and Cd2+ 
treated cells for up to 18 h (Additional file 4c; TCF3). 
LEF1, a marker of mesenchymal cells [35], could not be 
detected, indicating the epithelial characteristic of the cell 
line and absence of any epithelial-to-mesenchymal trans-
formation (EMT) phenomena upon Cd2+ treatment (data 
not shown). Similarly, no change was detected in E-cad-
herin mRNA expression which is suppressed during EMT 
via the Wnt pathway (reviewed in [36]) (Additional file 
4c; E-cadherin).
Discussion
To date, only one other transition metal ion, iron, has 
been reported to modulate the Wnt pathway [37]. How-
ever, this observation was made in cancer cell lines with 
non-functional APC or β-catenin mutations. In this 
study, we have described the activation of Wnt signaling 
by the carcinogen, Cd2+ in PTC. Specifically, Cd2+ induces 
Figure 6 Cd2+ triggers TCF4 up-regulation in kidney PTC. (A) TCF4 protein expression was increased by Cd2+ in whole cell lysates from PTC. (B) RT-
PCR of mRNA was performed with primers specific for rat TCF4 in WKPT-0293 Cl.2 cells without (ctl) or with Cd2+. Cd2+ increased TCF4 gene expression. 
(C) TCF4 expression in whole cell lysates of ~50% confluent and 100% confluent cells ± Cd2+ (25 μM for 6 h) by immunoblotting confirmed TCF4 up-
regulation induced by Cd2+ in subconfluent cells. (D) Actinomycin D abolished Cd2+-induced TCF4 up-regulation. PTC were treated with or without 
Cd2+ (25 μM) ± actinomycin D (ACT) (10 μg/ml, 1 h pre-incubation), a transcriptional inhibitor. Expression of TCF4 protein was determined in whole 
cell lysates of WKPT-0293 Cl.2 cells by immunoblotting.
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redistribution, but not upregulation, of β-catenin from 
disrupted AJs to the nucleus where it forms a complex 
with TCF4 to up-regulate a number of proto-oncogenes, 
including c-Myc, cyclin D1 and ABCB1. A very intriguing 
observation is the dependence of this Cd2+-induced Wnt 
signaling on cell confluence, which could be explained by 
the augmented levels of E-cadherin in confluent cells that 
prevent β-catenin translocation. Both TCF4 and β-
catenin orchestrate the transcription of Wnt target genes 
which promote proliferation and survival of affected cells. 
Thus we demonstrate induction of a novel pathway that 
could contribute to Cd2+ carcinogenesis in pre-neoplastic 
renal cells (Fig. 7).
In the absence of a Wnt signal, β-catenin is mostly associ-
ated with the AJ complex of epithelial cells [38]. The turn-
over of β-catenin is tightly regulated by the Axin-APC-
GSK3-β complex, which phosphorylates β-catenin and 
reinforces its degradation by the ubiquitin-proteasome 
pathway [39]. Mutations of components of the Wnt path-
way increasing signaling lead to cancers of epithelial tis-
sues (reviewed in [9]). For example, mutations in the β-
catenin/CTNNB1 gene have been reported in aggressive 
fibromatosis (also called desmoid tumor) and parathyroid 
tumors [40,41] and mutations in the APC gene are often 
found in colon cancers. Both lead to the accumulation of 
β-catenin in the cytoplasmic pool, since the destruction 
complex fails to prime β-catenin for degradation [42]. To 
our knowledge, no such mutations are present in our 
model cell line that could account for increased β-catenin 
stabilization in Cd2+-treated WKPT-0293 Cl.2 cells.
Alpha-catenin is another important component of AJs 
and is believed to have tumor suppressor functions, pos-
sibly by negatively regulating β-catenin mediated Wnt 
signaling [29]. In this study, α-catenin was released into 
the cytosol by Cd2+ exposure in kidney PTC, which is in 
line with other findings [43], and furthermore, we could 
demonstrate its translocation to the nuclei (Fig. 1C). 
However, reduced physical association between β-catenin 
and α-catenin was observed (Fig. 1D), suggesting that free 
rather than complexed β-catenin predominantly translo-
Figure 7 Model for the effects of Cd2+ on the adherens junction complex and Wnt signaling in WKPT-0293 Cl.2 kidney PTC. For further details, 
see discussion.
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cates to the nucleus. As β-catenin exists in the cells in at 
least five different distinct forms [44] it will be important 
to identify the form of β-catenin involved in the Cd2+-
induced Wnt response.
Aberrant expression of TCF4 is associated with various 
forms of cancer, including renal cell carcinoma (RCC) 
[45,46]. It was intriguing to observe that Cd2+ could 
induce transcription of TCF4 (Fig. 6) leading to increased 
accumulation of TCF4 in the nucleus. Little information 
is available about the transcriptional regulation of TCF4 
apart from a report by Saegusa et al. [46] which showed in 
endometrial carcinoma cells that β-catenin can directly 
induce transcription from the TCF4 promoter in a posi-
tive feed-back loop, with the effect being enhanced by the 
p300 co-activator. Whether this mechanism is also opera-
tive in Cd2+-induced TCF4 up-regulation warrants future 
investigation.
Interestingly, sub-confluent cells were more responsive to 
Cd2+ effects than confluent cells (Fig. 3). Confluent PTC 
revealed higher amounts of E-cadherin than sub-conflu-
ent cells, which can be explained by the fact that the for-
mer develop more cell-cell contacts and is in accordance 
with observations made in other cell systems [47]. E-cad-
herin repression or disruption is associated with cancer 
progression, invasiveness and is a key event in EMT [48]. 
On the other hand, E-cadherin expression is known to 
limit the degree and duration of Wnt/β-catenin signaling 
and EMT, possibly by increasing the turnover of cytosolic 
β-catenin due to the activity of an AJ-localized β-catenin 
phosphodestruction complex [47,49]. E-cadherin binding 
to β-catenin prevents nuclear localization of β-catenin 
and β-catenin/LEF-1-mediated transactivation [28,47]. In 
E-cadherin overexpressing cells, Cd2+-induced transloca-
tion of β-catenin was prevented (Fig. 4A) and cell prolif-
eration of PTC was slowed down (Fig. 4B), which is in 
accordance with previous studies [50], and Cd2+ cytotox-
icity was reduced (Fig. 4C). Suppression of anoikis, a form 
of programmed cell death triggered by complete loss of 
anchorage, has been suggested to account for the resis-
tance of E-cadherin overexpressing cells to detachment 
and death [51] and may contribute to our observations.
The E-cadherin/β-catenin interaction is largely domi-
nated by phospho-regulation where phosphorylation of 
E-cadherin by kinases, such as the Src family of kinases, 
decreases β-catenin binding affinity (reviewed in [52]). 
Cd2+ is known to induce a rapid activation of c-Src in 
mesangial cells [53], which is probably mediated by ROS 
formation [54]. Although Cd2+ can generate ROS in PTC 
[31,33] (Fig. 5A), the antioxidant α-tocopherol failed to 
prevent the effects of Cd2+ on β-catenin translocation 
(Fig. 5B) indicating that this phenomenon is rather 
caused by direct disruption of AJs by Cd2+, as first 
described by Prozialeck and coworkers (reviewed in [16]).
Cd2+ has recently been shown to induce apoptosis of 
LLC-PK1 PTC through ROS formation and induction of 
ER stress [33], where both branches of the pro-apoptotic 
unfolded protein response, the IRE1-XBP1 and ATF6-
CHOP pathways, were involved. The CCAAT/enhancer-
binding protein-homologous protein (CHOP) (also called 
growth arrest and DNA damage inducible protein 153 
(GADD153)) is a cell death marker that can act as Wnt 
repressor [34] and is expressed during ER stress of LLC-
PK1 cells induced by Cd2+ [55]. We could confirm CHOP 
induction by Cd2+ in WKPT-0293 Cl.2 cells (Fig. 5C). 
Although we found increased CHOP binding to TCF4 
upon Cd2+ exposure of WKPT-0293 Cl.2 cells (Fig. 5E), 
CHOP over-expression failed to prevent Cd2+-induced 
Wnt signaling. This could possibly be due to the elevated 
levels of TCF4 (Fig. 6) that could surpass the inhibitory 
effects of CHOP.
From a clinical perspective, recent studies have shown 
that renal ischemia can also trigger β-catenin/Wnt signal-
ing to promote survival of PTC, in part by inhibiting Bax 
in a phosphatidylinositol-3 kinase/Akt-dependent man-
ner [56]. The carcinogenicity and toxicity of Cd2+ has long 
been recognized [10] and could involve inactivation of 
the tumor suppressor p53 [57] or oxidative stress and 
inhibition of DNA repair (reviewed in [58]). Being a key 
signaling pathway for proliferation, the Wnt pathway 
could contribute to Cd2+ nephrocarcinogenesis by creat-
ing growth advantage [14]. Cd2+-induced ROS formation 
also triggers pathways (e.g. FOXO, NF-κB, HIF-1α, 
CHOP), which may cross-talk with the Wnt/β-catenin 
pathway and are involved in life-and-death decisions or 
adaptation to stress-induced damage [59]. We previously 
showed that Cd2+ triggers ABCB1 up-regulation in kid-
ney PT cells which was partly mediated by NF-κB activa-
tion and resulted in enhanced protection against Cd2+-
induced apoptosis [60]. Interestingly, the recent report by 
Solanas et al. [47] indicates that E-cadherin not only con-
trols the transcriptional activity of β-catenin but also that 
of NF-κB.
Accordingly, increased expression of Wnt target genes 
could contribute to increased proliferation, survival as 
well as decreased cell death of PT cells exposed to Cd2+ 
(but also other forms of stress-induced damage) and 
thereby promote Cd2+ carcinogenesis, since evasion of 
apoptosis is a critical step for the survival of damaged and 
mutated pre-neoplastic cells [61]. Hence, Cd2+-induced 
Wnt/β-catenin-TCF4 signaling opens a new avenue in 
understanding the mechanisms of carcinogenesis follow-
ing chronic Cd2+ exposure.
Conclusions
For the first time, we demonstrate that Cd2+ activates 
Wnt signaling in renal PT cells and that Cd2+-induced Chakraborty et al. Molecular Cancer 2010, 9:102
http://www.molecular-cancer.com/content/9/1/102
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transcription of target genes, including c-Myc, cyclin D1 
and Abcb1, is mediated by Wnt signaling. Interestingly, 
these effects depend on the cell density and proliferation 
status. Induction of the Wnt pathway by Cd2+ occurs by 
means of translocation of β-catenin to the nucleus and 
increased expression of the transcription factor TCF4, 
which can be prevented by E-cadherin overexpression. 
Cd2+-induced Wnt signaling, however, is independent of 
ROS formation and the pro-apoptotic ATF6/CHOP ER 
stress pathway triggered by Cd2+. We propose that Cd2+ 
may facilitate carcinogenesis of PT cells by inducing the 
Wnt pathway to promote proliferation and survival of 
pre-neoplastic cells.
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